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Abstract 29	
Introduction: Glutathione (GSH) pathways play a key role the metabolism and elimination 30	
of the neurotoxicant methylmercury (MeHg). We hypothesized that maternal genetic variation 31	
linked to GSH pathways could influence MeHg concentrations in pregnant mothers and 32	
children and thereby also affect early life development. 33	
Methods: The GCLM (rs41303970, C/T), GCLC (rs761142, T/G) and GSTP1 (rs1695, A/G) 34	
polymorphisms were genotyped in 1449 mothers in a prospective study of the Seychellois 35	
population with a diet rich in fish. Genotypes were analyzed in association with maternal hair 36	
and blood Hg, fetal blood Hg (cord blood Hg), as well as children’s mental (MDI) and motor 37	
development (PDI; MDI and PDI assessed by Bayley Scales of Infant Development at 20 38	
months). We also examined whether genotypes modified the association between Hg 39	
exposure and developmental outcomes. 40	
Results: GCLC rs761142 TT homozygotes showed statistically higher mean maternal hair Hg 41	
(4.12 ppm) than G carriers (AG 3.73 and GG 3.52 ppm) (p=0.037). For the combination of 42	
GCLC rs761142 and GCLM rs41303970, double homozygotes TT+CC showed higher hair 43	
Hg (4.40 ppm) than G+T carriers (3.44 ppm; p=0.018). No associations were observed 44	
between GSTP1 rs1695 and maternal hair Hg or between any genotypes and maternal blood 45	
Hg or cord blood Hg. The maternal GSTP1 rs1695 rare allele (G) was associated with a lower 46	
MDI among children (β=-1.48, p=0.048). We also observed some interactions: increasing Hg 47	
in maternal and cord blood was associated with lower PDI among GCLC rs761142 TT 48	
carriers; and increasing Hg in hair was associated with lower MDI among GSTP1 rs1695 GG 49	
carriers. 50	
Conclusions: Maternal genetic variation in genes involved in GSH synthesis is statistically 51	
associated with Hg concentrations in maternal hair, but not in maternal or fetal blood. We 52	
observed interactions that suggest maternal GSH genetics may modify associations between 53	
MeHg exposure and neurodevelopmental outcomes. 54	
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1 Introduction 58	
Fish is the main source of human low-level methylmercury (MeHg) exposure. At high levels, 59	
MeHg has clear detrimental effects on the nervous system (Clarkson et al. 2003), but the 60	
neurotoxic effects of low-level exposure are not established. The developing brain is 61	
particularly sensitive to neurotoxicants including MeHg (Costa et al. 2004; Johansson et al. 62	
2007), but it is unclear at what MeHg level the fetal brain is affected. Consequently, it is 63	
unclear if fish ingestion poses a risk for fetal toxicity. Research results of MeHg exposure 64	
from fish consumption in relation to neurodevelopmental outcomes in children have been 65	
contradictory between studies of different populations, with adverse associations observed in 66	
some studies (Grandjean et al. 1997; Vejrup et al. 2016), but not in others (Daniels et al. 67	
2004; Davidson et al. 1998; Llop et al. 2012; Strain et al. 2015). Several studies have 68	
suggested that genetics may contribute to MeHg body burden as well as to defense 69	
mechanisms against MeHg toxicity (Andreoli and Sprovieri 2017; Llop et al. 2015). 70	
An important mechanism in MeHg metabolism involves the conjugation of MeHg to the 71	
small tripeptide glutathione (GSH), which facilitates elimination of the conjugate in the bile 72	
via the ABC-transporter system (Ballatori and Clarkson 1985). The rate-limiting enzyme for 73	
GSH synthesis is γ-glutamyl-cysteine ligase (GCL), which is composed of a catalytic subunit 74	
(GCLC) and a modifier subunit (GCLM) (Lu 2013). Further, the conjugation of GSH to 75	
MeHg has been suggested to be catalyzed by glutathione S-transferases, particularly the pi 1 76	
isoform (GSTP1) (Custodio et al. 2004). Genetic polymorphisms in GCLC, GCLM, and 77	
GSTP1 have been linked to MeHg retention and body burden in adults (Barcelos et al. 2013; 78	
Custodio et al. 2004; Goodrich et al. 2011; Parajuli et al. 2016; Schlawicke Engstrom et al. 79	
2008). In addition, our group has recently shown that GSTP1 polymorphisms, expressed in 80	
Drosophila, may influence MeHg toxicity during development through both toxicokinetic and 81	
toxicodynamic mechanisms (Vorojeikina et al. 2017). 82	
Accordingly, we hypothesized that maternal polymorphisms in the GSH pathway could 83	
modify maternal MeHg body burden, and thereby influence MeHg exposure in the fetus and, 84	
as a consequence influence early child neurodevelopment. We have genotyped maternal SNPs 85	
in GCLM, GCLC and GSTP1 in 1449 pregnant women from a population in the Seychelles 86	
with a diet rich in fish and in whom no consistent adverse associations between maternal 87	
MeHg exposure and neurodevelopment were observed in their children (Strain et al. 2015; 88	
Strain et al. 2012; van Wijngaarden et al. 2017). SNPs were analyzed in association with 89	
MeHg biomarker concentrations in mothers (hair and blood) and children (cord blood), as 90	
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well as early neurodevelopmental outcomes in children (Bayley scales of infant development; 91	
BSID). The influence of an interaction between SNPs and biomarkers of MeHg exposure 92	
upon neurodevelopment endpoints was also studied, since antioxidative effects of glutathione 93	
may be protective against oxidative stress generated by MeHg (Kaur et al. 2006). 94	
   95	
2 Materials and methods 96	
2.1 Study population 97	
This prospective cohort consists of mother-child pairs from the Republic of Seychelles in the 98	
Indian Ocean and is of mixed African, European and East Asian origin. Participants were 99	
recruited for the Seychelles Child Development Study (SCDS) Nutrition Cohort 2 (NC2), a 100	
longitudinal observational study with the overall aim to investigate the effects of MeHg 101	
exposure from maternal fish consumption during pregnancy, nutritional status, and genetic 102	
predisposition on child developmental outcomes. NC2 consists of 1535 apparently healthy 103	
mothers recruited between the years 2008 to 2011 during their first antenatal visit (from 14 104	
weeks of gestation) at eight health centers across the main Island Mahé. Inclusion criteria for 105	
NC2 included being native Seychellois, being ≥16 y of age, having a singleton pregnancy, and 106	
having no obvious health concerns. Further information on recruitment criteria and power 107	
calculations for NC2 has previously been described (Strain et al. 2015). Mothers completed a 108	
retrospective fish use questionnaire at 28 weeks gestation, to estimate their weekly 109	
consumption of fish during pregnancy. Non-fasting blood samples were collected at 28 weeks 110	
gestation, and cord blood and maternal hair were collected at delivery. Whole blood samples 111	
were processed at the Public Health Laboratory at the Ministry of Health. One aliquot was 112	
shipped to the University of Rochester for Hg analysis and a second aliquot was shipped to 113	
Lund University for genotyping. 114	
For prenatal biomarker analyses, participants without genetic data and one each of thirty 115	
sibling pairs were excluded; also, missing data varied for the three biomarkers. (A flow chart 116	
of the participants included in this study is presented in Supplemental Figure S1). DNA from 117	
blood for genotyping was available for 1449 mothers. DNA and biomarker values were 118	
available for 1311, 1379, and 1004 mother child pairs for hair, maternal blood, and cord 119	
blood, respectively. For the BSID endpoints, exclusions were determined as described in 120	
Strain et al. (2015) and included pre- or perinatal deaths, maternal pre- or perinatal 121	
complications, birthweight<1500g, head trauma, twin births and seizures or disability. 122	
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Additionally, participants without genetic data and one each of thirteen sibling pairs were 123	
excluded. There were 1330 pairs eligible for models for the BSID endpoints, 1230, 1266, and 124	
935 of whom had samples of hair, maternal and cord blood respectively. The study was 125	
conducted according to guidelines laid down in the Declaration of Helsinki and all study 126	
procedures involving participants were reviewed and approved by the Seychelles Ethics 127	
Board, the Research Subjects Review Board at the University of Rochester, and the Regional 128	
Ethics Committee at Lund University, Sweden.  129	
2.2 Hg measurements 130	
Hair samples were cut at delivery and the longest available segment of maternal hair growing 131	
during gestation was analyzed assuming a hair growth rate of 1.1 cm/month. Total mercury in 132	
maternal hair during gestation is an established biomarker for prenatal MeHg exposure and 133	
has been used to monitor neurotoxicity of methylmercury; maternal hair Hg is known to 134	
correlate with infant brain Hg levels (Cernichiari, et al. 1995) and is believed to reflect the 135	
species of Hg that is transported across the blood-brain barrier (Clarkson & Magos, 2006). 136	
Total Hg in hair was measured by cold-vapor atomic-absorption-spectrometry (CVAAS) as 137	
previously described (Cernichiari et al.  1995) and reported in parts per million (ppm). Total 138	
Hg was measured on stored maternal and cord whole blood samples with atomic fluorescence 139	
spectrometry using a PSA Millennium Merlin System (PS Analytical, Kent, UK). The limit of 140	
detection for THg in maternal hair was 0.14 ppm and our limit of detection for Hg in blood 141	
was approximately 0.01 ng/mL, depending on sample volume (Pichichero et al. 2008). 142	
2.3 Neurodevelopmental assessment 143	
Toddlers completed developmental testing with the Bayley Scales of Infant Development 144	
(BSID-II) at 20 months (range: 15-32 months). The BSID-II yields two scores, the Mental 145	
Developmental Index (MDI) and the Psychomotor Developmental Index (PDI). Both scores 146	
are standardized with a Mean =100 and an SD=15. Testing was conducted by specially 147	
trained nurses at the Child Development Centre, Mahé. All study forms were shipped to the 148	
University of Rochester, where data were double-entered. Test reliabilities for the BSID-II 149	
were determined as previously described (Strain et al. 2008). 150	
2.4 Genetic analyses 151	
In this study, we selected genes encoding proteins with an important role in the GSH pathway 152	
for metabolising toxicants, including MeHg: two genes (GCLC and GCLM) encoding the 153	
rate-limiting enzyme for the synthesis of GSH (Lu 2013) as well as glutathione S-transferase 154	
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(GSTP1) respectively. The latter enzyme has been suggested to conjugate MeHg to GSH 155	
(Custodio et al. 2014). The selected SNPs included rs761142 (GCLC), rs41303970 (GCLM) 156	
and rs1695 (GSTP1) and are presented in Table 1. SNPs were selected based on a careful 157	
review of published literature (Llop et al. 2015) and we included only SNPs that had been 158	
shown to influence expression/regulation of the corresponding gene (i.e. rs761142 in GCLC 159	
and rs41303970 in GCLM) and/or main effect associations with Hg biomarker concentrations 160	
(i.e. rs41303970 in GCLM and rs1695 in GSTP1). In addition SNPs were selected with 161	
consideration to previously reported minor allele frequencies (MAFs) of relevant populations 162	
(i.e. African, Asian and European populations) and only SNPs with MAFs >5% were included 163	
in the study. GSTP1 rs1138272 was also considered but not included in the analyses due to 164	
low allele frequency (<1%) from preliminary genotyping of the NC1 cohort. This is in line 165	
with publicly available allele frequencies (http://www.ensembl.org) of this SNP in African 166	
populations (1%).  167	
DNA was extracted from maternal blood using the Qiagen DNA Blood Mini kit (Qiagen, 168	
Hilden, Germany). GCLC rs761142 and GSTP1 rs1695 were genotyped by TaqMan real-time 169	
PCR using custom assays from Thermo Scientific (Assay IDs C__2959418_20 and 170	
C_3237198_20 respectively). Reactions were analyzed on the ABI 7900HT Fast Real Time 171	
PCR System (Applied Biosystems, Thermo Fisher, Waltham, USA), using manufacturer’s 172	
recommended standard conditions. 173	
Due to the presence of several polymorphisms in the near vicinity of GCLM rs41303970, 174	
which prevented the design of optimal TaqMan assays, this SNP was instead genotyped by 175	
pyrosequencing. The assay was designed by PyroMark Assay Design 2.0 software (Qiagen) 176	
and included the following primer sequences: forward 5’CTGGCGGTCAGAGGACAG 177	
(biotinylated), reverse 5’GTGTAGGAAGCCCACCCTG and sequencing primer 178	
5’TGGGCGGAGCCGCGA. Primers target sequences flank the repeat, which allows the 179	
generation of a specific PCR product for sequencing. PCR was performed using PyroMark 180	
PCR reagents (Qiagen) according to manufacturer’s instructions and with negative controls 181	
included in each round of PCR. The PCR product was purified using Streptavidin Sepharose 182	
High Performance beads (Amersham Biosciences, UK) and pyrosequencing was carried out 183	
using the PyroMark reagents and PSQ HS96 Pyrosequencing System (Qiagen) according to 184	
manufacturer’s protocol. 185	
For quality control of genotyping data, >5% of samples were re-analyzed for all SNPs in a 186	
separate round of experiments with a 100% agreement between duplicates. Data quality was 187	
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also assessed by evaluating Hardy-Weinberg equilibrium using the conventional Chi-Square 188	
test. 189	
2.5 Statistical analyses 190	
Regression and analysis of variance (ANOVA) models for associations between SNPs and 191	
outcomes were performed based on an a priori analysis plan and all associations were 192	
evaluated using two-sided tests of significance at the α = 0.05 level. The associations for the 193	
combination of the GCLC and GCLM polymorphisms were also evaluated, since both of these 194	
genes are required to constitute a functional GCL protein. 195	
Under the assumption that fish consumption patterns and other determinants of MeHg 196	
exposure are similar for mothers with different SNPs, we used one-way ANOVA to estimate 197	
the association between each of the SNPs and Hg concentrations in the three biomarkers, in 198	
separate models. We used a 2 degree of freedom test to evaluate differences in hair, maternal 199	
blood, and cord Hg across the three levels of each SNP. We have seen that self-reported fish 200	
consumption is not well correlated to biomarkers of Hg and long chain PUFA in our cohorts. 201	
In this sample, the correlations between estimated fish consumption during pregnancy and 202	
maternal blood Hg (Spearman correlation coefficient=0.110), cord blood Hg (0.087), and 203	
prenatal hair Hg (0.047) are also small. Therefore, fish consumption cannot confound the 204	
relationship between the biomarkers of mercury and the genotypes and were not included in 205	
the analysis. Multiple linear regression was used to estimate the association of SNPs with 206	
BSID-II scores, adjusting for covariates previously chosen to cover the most important 207	
determinants of neurocognitive development in children (Strain et al. 2015). The covariates 208	
were child sex, maternal age at delivery, presence of two parents in the household, 209	
Hollingshead socioeconomic score, and child age at testing. These models for the BSID-II 210	
MDI and PDI, considered primary models, did not adjust for Hg because it is a potential 211	
mediator that would affect our ability to estimate the direct association between SNPs and 212	
BSID-II scores. Because no adjustment for Hg was made in these analyses, missing values for 213	
maternal hair Hg do not impact the number of observations included in the models. Therefore, 214	
our sample sizes for analyses between SNPs and BSID-II scores, which did not consider Hg 215	
variables, were considerably larger than those reported by Strain et al. (2015), in which Hg 216	
was the primary variable of interest. Since cord Hg values were missing for many subjects, 217	
we also repeated the maternal blood Hg analyses on the subsample of children with cord Hg 218	
samples. 219	
	 8	
To investigate whether polymorphisms in the GSH pathway could influence the relationship 220	
between maternal blood and cord blood Hg biomarker concentrations and neurodevelopment, 221	
we analyzed the interaction between SNPs and Hg biomarker concentrations on 222	
neurodevelopmental outcomes. In these secondary models for the BSID-II MDI and PDI, 223	
each biomarker for Hg was included as a covariate and we fit models with and without 224	
interactions of Hg and SNPs. Statistical analyses were undertaken using R (version 3.3.2; The 225	
R Foundation for Statistical Computing). 226	
 227	
3 Results 228	
3.1 Genetic characteristics   229	
All SNPs analyzed were in Hardy Weinberg equilibrium. SNP information and minor allele 230	
frequencies (MAFs) of NC2 in comparison with related populations are presented in Table 1. 231	
GCLM and GCLC MAFs were similar to other African populations however, GSTP1 for the 232	
Seychellois mothers showed a somewhat lower frequency (40% vs. 48%).  233	
3.2 Correlation between Hg biomarker concentrations and associations with 234	
neurodevelopmental outcomes 235	
Study population characteristics for the BSID-II models are presented in Table 2. Maternal 236	
hair Hg concentrations have previously been presented for this cohort and showed no 237	
association with child neurodevelopment (Strain et al., 2015), but the maternal blood and cord 238	
blood data have not been presented elsewhere. The correlations of maternal hair to maternal 239	
blood and cord blood Hg were 0.453 and 0.372 respectively, and the correlation between 240	
maternal and cord blood Hg was 0.664. No significant associations were observed between 241	
maternal blood or cord blood Hg with MDI scores (β=-0.0010, p=0.97 and β=0.0005, p=0.98 242	
respectively) or PDI scores (β=-0.0041, p=0.88 and β=0.0289, p=0.092 respectively). 243	
3.3 Associations of glutathione-related SNPs with maternal Hg concentrations 244	
Based on the functional effect of variant alleles, i.e. either lower gene expression or lower 245	
enzyme activity (Table 1), we hypothesized that carriers of the minor alleles would show 246	
higher Hg concentrations, i.e. a less efficient MeHg metabolism. However, in contrast to this 247	
expectation, there was a significant negative association (lower hair Hg) for the GCLC 248	
rs761142 rare allele G with maternal hair Hg (Table 3, Figure 1). Mothers homozygous for 249	
the rare allele (genotype GG) had 0.61 ppm lower adjusted mean maternal hair Hg on average 250	
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compared to those who were homozygous for the common allele (genotype TT). We also 251	
observed a non-significant (p=0.17) negative association (lower hair Hg) between the GCLM 252	
rs41303970 rare allele (T) and maternal hair Hg, with homozygous (genotype TT) having 253	
0.56 ppm lower adjusted mean hair Hg on average compared to CC. Combining the rs761142 254	
and rs41303970 genotypes increased the strength of associations between GCL genotype and 255	
maternal hair Hg; carriers of a rare allele in both genotypes (GCLC:GCLM combination 256	
GG/TG:TT/TC) showed on average a 0.87 ppm decrease in maternal hair Hg concentrations 257	
compared to individuals homozygous for both common alleles (TT:CC) (p<0.001, Table 3, 258	
Figure 1). There were no associations between GSTP1 rs1695 and maternal hair Hg and we 259	
did not observe any associations between the three SNPs and maternal blood Hg or cord 260	
blood Hg concentrations (Table 3). Associations between maternal hair Hg and GCLC, and 261	
the combination GCLC and GCLM remained significant in models fit to the smaller subset of 262	
subjects for which cord blood Hg values were available.  263	
3.4 Associations of GSTP1 rs1695 with early cognitive and psychomotor development 264	
Next we evaluated the influence of polymorphisms in the GSH pathway with early mental and 265	
motor development in children. The GSTP1 rs1695 rare allele G showed a significantly 266	
negative association with MDI scores (p=0.048) and a non-significant negative association 267	
with PDI scores (p=0.089). The rare allele homozygotes (GG) scored on average 1.5 points 268	
lower on the MDI scores and 1.7 points lower on the PDI scores compared to common allele 269	
homozygotes (genotype AA) (Table 4, Fig 2). We did not observe any primary associations 270	
for GCLM rs41303970 or GCLC rs761142 with mental or psychomotor development in the 271	
children. 272	
3.5 Association between Hg biomarker concentrations and neurodevelopment is modified 273	
by SNPs in GCLC and GSTP1  274	
We observed significant interactions of GCLC rs761142 with maternal blood Hg (p=0.002) 275	
and cord blood Hg (p=0.014) in the covariate-adjusted association with PDI scores (secondary 276	
associations; Figure 3A and B, Supplemental Table 1). For children of mothers with the TT 277	
genotype (associated with high Hg concentrations in maternal hair), there was a negative 278	
association with PDI scores for maternal blood Hg (β=-0.07 [CI -0.15, 0.01]) and cord blood 279	
Hg (β=-0.07 [CI -0.12, -0.03]), while for children of mothers with the GG genotype 280	
(associated with low Hg concentrations in maternal hair) the associations with the PDI scores 281	
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were positive (β=0.23 [CI 0.08, 0.39] for maternal blood Hg and β=0.08 [CI -0.02, 0.18] for 282	
cord blood). 283	
There were also significant interactions between GSTP1 rs1695 genotype and maternal hair 284	
Hg on the MDI scores (p=0.03). There was a stronger negative association between maternal 285	
hair Hg and the MDI scores for children of mothers with the GG genotype (β=-0.57 [CI -1.02, 286	
-0.12]) compared to AA (β=-0.15 [CI -0.44, 0.15]; Figure 3C,	Supplemental Table 1). None of 287	
the other secondary models considered had a significant interaction.   288	
 289	
4 Discussion 290	
In this study of a population eating a fish-rich diet, we have shown that maternal genotype of 291	
GSH-related genes is associated with both Hg concentrations in the mother’s hair and early 292	
neurodevelopmental outcomes in the child 293	
In contrast to our expectations, we observed a negative association of the GCLC rs761142 294	
rare allele G with maternal hair Hg and the association increased in strength in combination 295	
with the GCLM rs41303970 rare allele T. However, there were no association of these SNPs 296	
with maternal or cord blood Hg whereas associations of SNPs with hair Hg remained 297	
significant among the subset of subjects with cord blood measures. The fewer associations of 298	
SNPs with blood Hg compared to hair Hg suggests that blood Hg is less influenced by genetic 299	
factors than hair Hg. We have previously shown, in this same cohort, that genetic variation in 300	
ABC transporter genes also show associations with maternal hair Hg (Engstrom et al. 2016) 301	
implying that genetics needs to be taken into consideration when using hair Hg as a biomarker 302	
of MeHg exposure. This finding is reflects what is seen for other metal biomarkers that in 303	
some cases show a significant influence of genetics, e.g. for manganese concentrations in 304	
blood (Wahlberg et al. 2016) and teeth (Wahlberg et al. 2017), as well as for urinary arsenic 305	
metabolites used as proxy for inorganic arsenic exposure (Schlawicke Engstrom et al. 2007). 306	
Although we did not find any associations between the SNPs and either maternal or cord 307	
blood Hg, this does not rule out a possible genetic influence of GSH pathway polymorphisms 308	
on these biomarkers. Previous studies of GCLM rs41303970 with Hg body-burden showed 309	
positive associations (higher Hg) of the rare allele with Hg in erythrocytes (Schlawicke 310	
Engstrom et al. 2008) and with Hg in blood (Barcelos et al. 2013; Harari et al. 2012; 311	
Schlawicke Engstrom et al. 2008), whereas, associations with faster Hg elimination (Harari et 312	
al. 2012) and lower Hg concentrations in blood have also been found (de Oliveira et al. 2014).  313	
	 11	
Another factor that could have masked potential association of GSH SNPs with maternal 314	
blood Hg concentrations is the expansion of the blood compartment during pregnancy which 315	
may cause larger variations in plasma volumes between individuals and thus influence blood 316	
Hg concentrations.   317	
GCLC rs761142 is an intronic SNP that has been associated with reduced GCLC mRNA in 318	
human livers and lymphocytes (Wang et al. 2012). SNP rs41303970, which is situated in the 319	
GCLM promoter region, and has been associated with reduced transcriptional promoter 320	
activity (Nakamura et al. 2002). Thus, the functional consequences predicted from these two 321	
SNPs would be lower GCLM and GCLC protein levels for the variant allele carriers which 322	
we hypothesized could lead to reduced GSH synthesis, impaired Hg elimination and 323	
ultimately more Hg retained in the body. In contrast we found that variant allele carriers of 324	
GCLM and GCLC SNPs correlated with lower Hg levels in hair and no associations with 325	
blood Hg levels. Conflicting results for polymorphisms in GCLC and GCLM, have been 326	
reported among several studies (Llop et al, 2015) which, as suggested by Wang et al (2012), 327	
could indicate tissue/cell or environmental specificity of regulatory SNPs in GCLC and 328	
GCLM. Evidence for tissue-specific regulation of the GCLC rs761142, where the variant 329	
allele shows higher expression in some tissues and lower expression in others, can be found in 330	
the GTEx Portal data base (data were obtained from the GTEx Portal www.gtex.org on 331	
02/15/18). For GCLM rs41303970, all tissues show lower expression for variant carriers. 332	
Samples suitable for gene-expression analyses will be necessary to investigate this hypothesis 333	
further, but were not available for the present study. Our findings also highlight the need for 334	
additional functional studies to differentiate unique aspects of MeHg transport and fate in hair 335	
versus blood. 336	
In addition to the associations of GCLC rs761142 with hair Hg levels alone, the associations 337	
between Hg in maternal and cord blood and early motor development in children were 338	
significantly different in GCLC rs761142 carriers. While a weak negative association between 339	
Hg concentrations and PDI was observed for the common allele homozygotes, the rare allele 340	
homozygotes showed instead a positive association, indicating that this SNP may be 341	
protecting against Hg exposure in the infant. This unanticipated positive association of Hg 342	
and neurodevelopmental outcome suggests that additional factors that influence MeHg 343	
distribution within body compartments or toxicodynamics at the target organ (e.g. the brain) 344	
can overcome the toxicity implicated by a measure of body burden inferred from a given 345	
biomarker. Another explanation could be that the interaction is instead a reflection of the 346	
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child’s own genotype that influences Hg elimination after birth and subsequent 347	
neurodevelopment in the infant.  348	
For GSTP1 rs1695 we did not observe an association between genotype and any of the Hg 349	
biomarker concentrations. Instead we observed a weak negative influence of the rare allele on 350	
neurodevelopment as well as negative interaction of the rare allele with maternal hair Hg on 351	
mental development, which implies that this allele may increase the sensitivity to Hg 352	
exposure in the child. The GSTP1 rs1695 rare allele (G) causes a substitution of isoleucine 353	
(Ile) with valine (Val), which has shown to cause lower catalytic activity of the enzyme (Ali-354	
Osman et al. 1997; Vorojeikina et al. 2017). In some population studies, the rare allele has 355	
been associated with lower Hg in hair (Goodrich et al. 2011) and blood (Schlawicke 356	
Engstrom et al. 2008, Parajuli et al 2016); however, there are also several studies in which 357	
associations between this SNP and Hg retention have been assessed without showing any 358	
significant effects (Barcelos et al. 2013; Custodio et al. 2005; Engstrom et al. 2011). The 359	
absence of an association between GSTP1 rs1695 and Hg biomarkers implies that the 360	
association of this SNP with neurological development may be mediated by mechanisms 361	
other than Hg kinetics. This hypothesis is supported by the findings from a recent study 362	
assessing developmental effects of MeHg in Drosophila expressing variants of human 363	
GSTP1. In flies, where wild type GSTP1 expression induces MeHg tolerance, the protein 364	
encoded by the rs1695 rare allele proved less enzymatically active and required higher 365	
expression levels to achieve MeHg tolerance to the same level as the wild type GSTP1 366	
(Vorojeikina et al. 2017). Interestingly, the protective effects of GSTP1 expression were not 367	
seen to strictly correlate with reduced Hg body burden in Drosophila, as Hg body burden was 368	
seen to vary depending on the target tissue in which GSTP1 was expressed (Vorojeikina et al. 369	
2017). Consistent with our findings here, these results suggest GSTP1 is likely to influence 370	
Hg toxicodynamics rather than kinetics. In addition to its role in GSH conjugation, GSTP1 is 371	
also an important factor in the defense against oxidative stress (Sanchez-Gomez et al. 2016), 372	
and thus, the less active variant of enzyme may increase susceptibility to Hg induced 373	
oxidative stress. Still, due to the small effect sizes observed for associations between GSTP1 374	
genotypes and developmental outcomes in this study, these associations need to be interpreted 375	
cautiously. 376	
One strength of this study is the large size and unique cohort attributes of Seychellois mother 377	
and child pairs, which, due to their diet rich in fish and consequently high Hg concentrations, 378	
are well suited for studies of Hg toxicity and susceptibility factors. The cohort includes a 379	
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comprehensive data set which enables comparisons of Hg concentrations in different tissues 380	
with children’s neurological outcomes. Limitations of this study are the candidate-gene-study-381	
design which, in comparison to a genome wide approach, may provide a less complete picture 382	
of the influence of genetic polymorphisms on Hg toxicity. Another limitation is the lack of 383	
samples for gene-expression analyses which would have provided a further level of 384	
understanding of the mechanisms behind the observed associations. 385	
In conclusion, our results indicate that maternal genetic variation in GSH related genes 386	
potentially influence maternal MeHg metabolism and may also modify associations between 387	
MeHg exposure and developmental outcomes. The findings contribute to increased 388	
understanding of the health impact of a fish-rich diet during pregnancy, and how this may 389	
differ not only between populations, but among individuals within a population. A next step 390	
for future studies is to examine the influence of children’s genetic variation in GSH related 391	
genes on Hg toxicokinetics and dynamics during development. 392	
 393	
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Table	1.	SNP	information	and	minor	allele	frequencies	(MAFs)	in	the	study	cohort	of	Seychellois	mothers	(NC2)	compared	to	other	populations	
	 	
	 	 MAF	(%)	
Gene	/	
Chromosome	
SNP	/	Allelesa	 SNP	typeb	
Functional	effect	of	minor	
allele/Hypothesized	effect	on	Hg	
concentrations		
NC2	 Africac	 South	Asiac	 Europec	
GCLM	
1	
rs41303970	
C/T	
Upstream	variant	
Reduced	GCLM	promoter	activity	
(Nakamura	et	al.	2002)/Higher	Hg	
23	 22	 9	 15	
GCLC	
6	
rs761142	
T/G	
Intronic	variant	
Reduced	GCLC	gene-transcription	
(Wang	et	al.	2012)/Higher	Hg	
34	 37	 37	 27	
GSTP1	
11	
rs1695	
A/G	
Missense	
Ile/Val	
Reduced	enzyme	activity	
(Ali-Osman	et	al.	1997;	Goodrich	and	
Basu	2012)/Higher	Hg	
40	 48	 30	 33	
GSTP1		
11	
rs1138272	
C/T	
Missense	
Ala/Val	
Reduced	enzyme	activity	
(Ali-Osman	et	al.	1997;	Goodrich	and	
Basu	2012)/Higher	Hg	
N/Ad	 1	 7	 7	
a	Minor	allele	is	denoted	last.	
b	Source:	the	National	Centre	for	Biotechnology	Information	(https://www.ncbi.nlm.nih.gov)	
c	Average	MAFs	for	African,	South	Asian	and	European	populations.	Source:	Ensembl	Genome	Browser	(http://www.ensembl.org)	
d	GSTP1	rs1138272	was	considered	but	not	included	in	the	analyses	due	to	low	allele	frequency	(<1%)	from	preliminary	genotyping	of	another		
cohort	from	Seychelles.	 	
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Table	2.	Characteristics	of	study	population	including	summary	statistics	of	outcomes	and	covariates	for	mother/child	pairs	used	in	the	BSID	
models.	These	data	include	48%	female	children	and	73%	children	living	with	two	parents	at	the	time	of	BSID	testing.	
Variable	 N	available	 N	missing	 Mean	 SD	 Min	 25	percentile	
50	
percentile	
75	
percentile		
	
Max	
Maternal	hair	Hg	(ppm)	 1230	 100	 3.87	 3.43	 0	 1.44	 2.88	 5.13	 31.66	
Maternal	blood	Hg	(µg/L)	 1266	 64	 18.22	 10.86	 1.87	 10.84	 15.80	 22.83	 84.15	
Cord	blood	Hg	(µg/L)	 935	 395	 34.48	 20.46	 1.91	 20.01	 30.15	 43.91	 181.27	
MDI	at	20	months	 1326	 4	 87.6	 10.7	 49	 82	 88	 94	 118	
PDI	at	20	months	 1324	 6	 96.7	 10.6	 49	 90	 97	 104	 136	
SES	 1330	 0	 32.0	 10.35	 11	 24	 31.5	 39.5	 63	
Maternal	age	at	delivery	(years)	 1330	 0	 27.1	 6.3	 16.3	 22.1	 26.1	 31.5	 44.8	
Child	test	age	(months)	 1330	 0	 20.3	 1.4	 15	 20	 20	 21	 32	
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	Table	3.	Associations	of	genotypes	with	MeHg	biomarker	concentrations.	When	the	mean	MeHg	concentrations	differ	significantly	across	
genotype	levels	based	on	a	2	df	test	(p-value	2),	the	mean	differences	from	the	reference	genotype	(β)	are	also	given	with	their	p-values	(p	1).	
	 	 Maternal	Hair	 Maternal	Blood	 Cord	blood	
Genes	 Genotypes	 Mean	 CI	 β  p	1	 n	 Mean	 CI	 n	 Mean	 CI	 n	
GCLM	 CC	 4.07	 (3.82,4.32)	 	 	 722	 18.28	 (17.50,19.06)	 808	 34.84	 (33.13,36.55)	 557	
	 CT	 3.63	 (3.31,3.96)	 	 	 427	 18.46	 (17.44,19.48)	 486	 34.34	 (32.11,36.57)	 326	
	 TT	 3.22	 (2.40,4.05)	 	 	 67	 16.74	 (14.11,19.38)	 72	 31.64	 (25.50,37.78)	 43	
p-value	2	 	 0.166	 	 	 	 	 0.649	 	 	 0.529	 	 	
GCLC	 TT	 4.12	 (3.83,4.42)	 	 	 527	 18.43	 (17.51,19.35)	 585	 34.44	 (32.43,36.45)	 395	
	 TG	 3.73	 (3.44,4.01)	 -0.46	 0.02	 562	 18.01	 (17.14,18.89)	 637	 34.59	 (32.67,36.52)	 430	
	 GG	 3.52	 (2.95,4.09)	 -0.61	 0.06	 138	 18.28	 (16.47,20.08)	 155	 33.60	 (29.74,37.45)	 107	
p-value	2	 	 0.037	 	 	 	 	 0.776	 	 	 0.876	 	 	
GCLC/M	 TT&CC	 4.40	 (4.01,4.79)	 	 	 296	 18.40	 (17.17,19.63)	 327	 35.41	 (32.71,38.11)	 219	
	 G-&CC	 3.86	 (3.54,4.19)	 -0.58	 0.02	 423	 18.18	 (17.17,19.20)	 478	 34.29	 (32.11,36.47)	 335	
	 TT&T-	 3.74	 (3.29,4.19)	 -0.52	 0.08	 225	 18.46	 (17.04,19.88)	 253	 33.20	 (30.15,36.24)	 172	
	 G-&T-	 3.44	 (3.03,3.85)	 -0.87	 0.00	 269	 18.05	 (16.76,19.34)	 305	 34.75	 (31.90,37.59)	 197	
p-value	2	 	 0.018	 	 	 	 	 0.839	 	 	 0.766	 	 	
GSTP1	 AA	 3.82	 (3.50,4.14)	 	 	 446	 18.44	 (17.44,19.44)	 502	 33.75	 (31.54,35.95)	 333	
	 AG	 3.92	 (3.64,4.20)	 	 	 580	 18.29	 (17.41,19.16)	 653	 35.10	 (33.20,36.99)	 450	
	 GG	 3.82	 (3.34,4.29)	 	 	 202	 17.64	 (16.17,19.11)	 223	 34.27	 (31.00,37.54)	 151	
p-value	2	 	 0.968	 	 	 	 	 0.643	 	 	 0.766	 	 	
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Table	4.	Associations	of	genotypes	with	developmental	outcomes	adjusted	for	covariates.a	When	the	outcome	means	differ	significantly	across	
genotype	levels	based	on	a	2	df	test	(p-value	2),	the	mean	differences	from	the	reference	genotype	(β)	are	also	given	with	their	p-values	(p	1).	
	 	 MDI	 PDI	
Genes	 Genotypes	 Mean	 CI	 β  p	1	 n	 Mean	 CI	 n	
GCLM	 CC	 87.75	 (87.02,88.48)	 	 	 783	 96.68	 (95.94,97.42)	 782	
	 CT	 87.41	 (86.46,88.37)	 	 	 458	 96.75	 (95.78,97.72)	 457	
	 TT	 86.47	 (84.03,88.92)	 	 	 70	 96.44	 (93.96,98.93)	 70	
p-value	2	 	 0.690	 		 	 	 	 0.995	 		 	
GCLC	 TT	 87.65	 (86.79,88.51)	 	 	 564	 96.98	 (96.11,97.85)	 562	
	 TG	 87.58	 (86.75,88.41)	 	 	 610	 96.63	 (95.80,97.47)	 611	
	 GG	 87.42	 (85.74,89.09)	 	 	 149	 95.75	 (94.05,97.45)	 148	
p-value	2	 	 0.759	 		 	 	 	 0.371	 		 	
GCLC/M	 TT&CC	 88.07	 (86.92,89.22)	 	 	 317	 96.60	 (95.43,97.77)	 315	
	 G-&CC	 87.49	 (86.54,88.44)	 	 	 463	 96.66	 (95.70,97.63)	 464	
	 TT&T-	 87.07	 (85.75,88.39)	 	 	 241	 97.39	 (96.05,98.73)	 241	
	 G-&T-	 87.49	 (86.28,88.70)	 	 	 287	 96.13	 (94.91,97.36)	 286	
p-value	2	 	 0.721	 		 	 	 	 0.353	 		 	
GSTP1	 AA	 88.60	 (87.67,89.54)	 	 	 477	 97.50	 (96.56,98.45)	 475	
	 AG	 87.02	 (86.21,87.84)	 -1.59	 0.012	 626	 96.36	 (95.54,97.18)	 626	
	 GG	 87.12	 (85.75,88.50)	 -1.48	 0.079	 221	 95.83	 (94.44,97.22)	 221	
p-value	2	 	 0.048	 		 	 	 	 0.089	 		 	
a	The	models	were	adjusted	for	child	sex,	maternal	age	at	delivery,	presence	of	two	parents	in	the	household,	Hollingshead	socioeconomic	score,	
and	child	age	at	testing.	
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Figure legends 1	
 2	
Figure 1. Associations of GCLM rs41303970 (A) and GCLC rs761142 (B) genotypes 3	
separately and in the combination rs761142:rs41303970 (C) with maternal prenatal Hg hair 4	
concentrations including 95% confidence intervals (CI). To simplify combinations of GCLC 5	
and GCLM genotypes, heterozygotes and rare allele homozygotes for each SNP were 6	
combined into groups representing rare allele carriers. *p≤0.10, **p≤0.05, ***p≤0.01 7	
 8	
Figure 2. Associations between GSTP1 rs1695 genotypes and children’s mental development 9	
index (A) and motor development index (B) at 20 months. *p≤0.10, **p≤0.05, ***p≤0.01 10	
 11	
Figure 3. Associations between Hg biomarker concentrations and children’s neurological 12	
development showing significant differences in slopes across genotype levels. (A) Association 13	
between maternal blood Hg and the PDI with separate slopes by levels of GCLC rs761142, 14	
(B) association between maternal blood Hg and the PDI with separate slopes by levels of 15	
GCLC rs761142, and (C) association between maternal hair Hg and the MDI with separate 16	
slopes by levels of GSTP1 rs1695.  17	
	18	
**		 *		A	 B	
